CARMAT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.46 EUR | -8.47% |
|
-8.95% | -48.36% |
| Mar. 25 | Carmat: final agreement with creditors | CF |
| Mar. 25 | Carmat Secures Two-year Extensions for Bank Loans | MT |
Presenter SpeechStéphane Piat (Executives)[Audio Gap] [indiscernible] Carmelo Milano from Duke...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.46
EUR
Average target price
14.22
EUR
Spread / Average Target
+310.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -48.36% | 100M | |
| +12.49% | 127B | |
| -8.82% | 10.68B | |
| -2.20% | 8.59B | |
| +15.12% | 7.09B | |
| +26.97% | 5.07B | |
| +7.09% | 3.39B | |
| +0.27% | 3.04B | |
| -10.28% | 2.02B | |
| -8.61% | 2B |
- Stock Market
- Equities
- ALCAR Stock
- News CARMAT
- Transcript : Carmat SA - Special Call
